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Epithelial cells and adhesion molecules 
In recent years it has become increasingly clear 
that asthma is a complex inflammatory disorder of 
the airways involving the interaction of a number of 
different cell types and it is likely that several different 
mechanisms are implicated. One such mechanism 
which is the focus of much current attention is the 
attraction of inflammatory cells to the site of inflam- 
mation and their retention. The understanding of the 
mechanisms by which these cells communicate has 
become a fascinating arena of ever increasing global 
research interest and is believed to involve adhesion 
molecules. 
There are four main families of adhesion mol- 
ecules: the immunoglobulin superfamily, the inte- 
grins, the selectins and the cadherins. These 
molecules play an important role in the transmigra- 
tion of leucocytes through the endothelial wall which 
is an essential precursor to the accumulation of cells 
at the site of inflammation. The initial stage involves 
the selectins which promote the rolling of leucocytes 
along the endothelial wall and later phases, including 
sticking and diapedesis, are controlled by the inte- 
grins and members of the immunoglobulin super- 
family. However, adhesion molecules also play an 
important role in the retention of leucocytes at the 
site of inflammation. 
Over the last few years there has been increasing 
interest in the role played by epithelial cells in inflam- 
matory diseases. It is now clear that bronchial epithe- 
lial cells which were once thought to be merely a 
barrier preventing the entry of noxious substances 
into the lung, are now recognized as playing an active 
role in the inflammatory reaction. These cells are 
capable of the synthesis and release of a range of 
mediators including cicosanoids (1) and cytokines 
(2), have been shown to express cell surface markers 
and are capable of interacting in the cellular network. 
There is a mounting body of evidence to suggest that 
bronchial epithelial cells are capable of playing an 
important role in asthma by the attraction and 
retention of inflammatory cells into the airways by 
means of adhesion molecules. 
The first demonstration that primate bronchial 
epithelial cells are capable of expressing adhesion 
molecules was given by Wegner and colleagues in 
1990 (3), when they demonstrated that these cells 
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expressed ICAM- following exposure to allergen. In 
the same study, they showed that anti-ICAM- anti- 
bodies were blocking the eosinophil inilux following 
allergen challenge but they did not investigate at 
which levels this inhibition occurred. Since then a 
number of studies has been performed to investigate 
the expression of these molecules in normal subjects 
and in those suffering from asthma or other pulmo- 
nary diseases; some interesting differences in the 
results have been observed. In a study, using bron- 
chial biopsies, performed by Montefort and col- 
leagues, (4) whilst low levels of ICAM- were 
detected on the bronchial epithelium of all asthmatic 
and 70% of normal subjects, no difference could be 
detected between the basal levels of this molecule in 
the two groups. However, this study does not accord 
with Tonne1 et al. who, using tissue obtained in the 
same manner, showed an increased expression of 
ICAM- on the epithelium of asthmatics by compari- 
son with normal subjects (5). Using epithelial cells 
recovered by bronchial brushing, we found not only a 
significant difference in the basal levels of expression 
between normals and asthmatics but also a correla- 
tion between the expression of this molecule or 
HLA-DR and the severity of the disease as assessed 
by the score of Aas (6). The reasons for these 
differences are unclear, but it is unlikely that the 
different methodologies used (bronchial biopsies in 
the Southampton study and bronchial brushing in 
our laboratory) account for the different results 
obtained. Indeed, earlier work in our laboratory 
using bronchial biopsies, mechanically dispersed, 
demonstrated a difference in surface molecule expres- 
sion between normal and asthmatic subjects (7). The 
discrepancy may be due, at least in part, to differ- 
ences in the subjects selected. The asthmatic group 
studied by Montefort et al. had a mean FEV, of 
104% of the predicted value whilst the group studied 
in our laboratory had a mean FEV, of 86% of the 
predicted value. Vignola et al. found that the level of 
expression of ICAM- is correlated with the severity 
of the disease, it is possible that the severity of disease 
in the asthmatic group studied by Montefort et al. 
was not sufficient for a difference to be detected. 
These discrepancies underline the need for standard- 
ization of patient groups in order to allow direct 
comparisons to be made between different research 
centres. 
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The mechanisms leading to the increased expres- 
sion of ICAM-I on epithelial cells are not fully 
understood but it is clear that a number of cytokines 
including interferon-y, TNFa and IL-l (8-10) are 
capable of upregulating this expression. It is also 
possible that inflammatory cells infiltrating the air- 
ways may be capable of influencing the expression of 
these adhesion molecules. It has been demonstrated 
that there is an infiltration of eosinophils into the 
bronchial mucosa in asthmatics and that these cells 
are activated (11). Moreover, addition of eosinophil- 
derived proteins such as major basic protein and 
eosinophil cationic protein to human nasal epithelial 
cells significantly augment the expression of ICAM-I 
(10). Another cell- type which is found between the 
epithelial cells, particularly in asthma, is the mast 
cell. These cells appear to be partly degranulated and 
it has been shown that receptors for histamine are 
present on bronchial epithelial cells (12). In recent 
experiments we have demonstrated that addition of 
histamine to bronchial epithelial cells of normal 
subject results in an increase in the expression of 
ICAM- as well as the class II human leucocyte 
antigen HLA-DR (13). It therefore appears that 
adhesion molecules represent the end point of a 
number of pathways and it is evident that many 
different stimuli are capable of upregulating their 
expression. This may explain why no distinction can 
be made between extrinsic and intrinsic asthma or 
between patients with mild as compared with a severe 
form of the disease. 
The precise role of the expression of ICAM-I in 
asthma still remains to be elucidated. Whilst it is 
likely that increased expression of this marker is 
involved in the cellular infiltration characteristic of 
this disease, particularly by eosinophils, it is also 
possible that ICAM- may be important in viral 
infections. It has been demonstrated that ICAM- is 
the major surface receptor virus for rhinovirus (14) 
and it has been suggested that a viral infection is 
involved in approximately half of childhood asth- 
matic attacks (15,16). It is possible that a positive 
feedback network is involved in the binding of 
viruses to epithelial cells since it has shown that 
Haemophilus injuenzae endotoxin (17) and Para- 
inlluenza virus type 2 (18) are capable of increasing 
the expression of ICAM-I on human airways epithe- 
lial cells. The increased expression of adhesion mol- 
ecules on epithelial cells may also play an important 
role in the retention of inflammatory cells in the 
airways. Our studies have demonstrated that 
ICAM-I is expressed mainly on the apical portion of 
the ciliated epithelial cell which may serve to retain 
cells in the airway lumen and Altman et al. (10) have 
observed that the increased expression of ICAM-I on 
nasal epithelial cells was associated with an increased 
adhesion of neutrophils. Thus, adhesion molecules 
would be of importance not only in the extravasation 
of inflammatory cells at the endothelial level, but 
also may participate in the persistence of these cells at 
the inflammatory site as a result of interactions 
between inflammatory cells and extracellular matrix 
or epithelial cells. 
If expression of ICAM-I is taken as being indica- 
tive of inflammation in asthma, then anti-adhesion 
therapy may well find a place in the treatment of 
asthma as has been suggested by Barnes (19) and it 
has been shown that anti-ICAM- antibodies block 
the adherence of neutrophils to human airway epi- 
thelial cells (20). Some studies on the effects of 
various drugs including corticosteroids (21) have 
shown that ICAM-I expression on epithelial cells can 
be down-regulated and anti-histamines such as pyril- 
amine and ranitidine (13) as well as loratadine and 
nedocromil sodium (unpublished data) inhibit the 
histamine-induced expression of ICAM-I on bron- 
chial epithelial cells but further work on the relevance 
of these studies in asthma is required. 
In conclusion, it appears likely that adhesion mol- 
ecules play an important role in asthma and may 
represent one way in which the epithelium interacts 
with other cell types present in the lung to enhance 
inflammatory processes. The future of anti-adhesion 
therapy for the control of this disease may well prove 
to be an interesting and fruitful area of research 
leading to new therapeutic strategies. 
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